BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 10, 2026
Home » Authors » James Etheridge

Articles by James Etheridge

Innate Pharma Plans To Launch IPO On Euronext

Oct. 31, 2011
By James Etheridge
No Abstract
Read More

Transgene Signs Pact To Work With National Cancer Institute

Oct. 31, 2011
By James Etheridge
No Abstract
Read More

Eurofins Scientific Aims To Become World-Class CRO

Oct. 31, 2011
By James Etheridge
No Abstract
Read More

Biosystems International Aiming For Drug, Diagnostic Biomarkers

Oct. 31, 2011
By James Etheridge
No Abstract
Read More

Cerep and PerkinElmer Expand Assay Offering

May 6, 2009
By James Etheridge

NicOx Buys NitroMed's Nitric Oxide Patents

April 29, 2009
By James Etheridge

SpePharm Seeking €35M from BioAlliance Pharma

April 22, 2009
By James Etheridge
No Abstract BioWorld International CorrespondentPARIS - SpePharm Holding BV plans to file a claim against BioAlliance Pharma SA for financial damages and losses of at least €35 million (US$45.3 million).
Read More

Biocortech Initiates Trial of Depression Blood Test

April 15, 2009
By James Etheridge

BioAlliance Begins Arbitration Against SpePharm, SpeBio

April 8, 2009
By James Etheridge

TcLand, Genedata Collaborate on Autoimmune Biomarkers

April 1, 2009
By James Etheridge
Previous 1 2 3 4 5 6 7 8 9 … 90 91 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing